Dr. Samuel R. Schroeder, MD

Dr. Schroeder practices at UnityPoint Health - Iowa Methodist Medical Center in Des Moines, Iowa, part of UnityPoint Health.

Dr. Schroeder's NPI, 1861871105, was assigned on May 19, 2015. Dr. Schroeder holds Iowa license MD-47064.

Dr. Schroeder's primary practice is UnityPoint Health - Iowa Methodist Medical Center, at 1200 Pleasant Street, Des Moines, IA 50309 in Polk County. The practice phone is (515) 343-1000.

Dr. Schroeder's primary practice is UnityPoint Health - Iowa Methodist Medical Center in Des Moines, Iowa, part of UnityPoint Health. Dr. Schroeder is also affiliated with MercyOne Des Moines Medical Center. The medical group on file is East Des Moines Family Care Center (currently publicly listed as UnityPoint Clinic Family Medicine - East Des Moines). Dmand AI also links Dr. Schroeder to 3 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schroeder practices, 6 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Schroeder's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Schroeder is licensed in Iowa.

CMS data shows 3,127 Medicare services from Dr. Schroeder across 20 procedure codes in 2024, for 393 Medicare patients. Medicare paid $187,046 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 393 Medicare patients who saw Dr. Schroeder in 2024. The largest group is 65 to 74, with 199 patients. 75% of them have cancer, and 75% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Schroeder's median patient age at 74, with 39% women.

In 2024, Dr. Schroeder wrote 225 Medicare Part D claims for 89 patients. 87% of them were for generic drugs. CMS names the drug for 127 of them, across 5 drugs with 11 or more claims each, at $1,565 in total drug cost. In 2023, CMS named 150 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Schroeder for performance year 2024, reported as part of a group. Dr. Schroeder accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Schroeder as offering telehealth.

Dmand AI links 14 papers to Dr. Schroeder, published from 2013 to 2022. 2016 was the busiest year, with 2. The most frequent topics are Ascorbic Acid, Mice, Nude and Pancreatic Neoplasms. Dr. Schroeder has published most often in Cancer Res. Dr. Schroeder's most frequent co-authors are Joseph J. Cullen, MD, Kevin V. Albuquerque, MD and Robert Dale Timmerman, MD.

CMS Open Payments shows 29 general payments to Dr. Schroeder from 14 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Novocure Inc. paid the most, $388.